(Q44675764)

English

In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 December 2017

In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor (English)

1 reference

Europe PubMed Central

5 December 2017

0 references

1 reference

based on heuristic

inferred from title

Johannes Pieter Albert Baak

2

object named as

Jan P A Baak

1 reference

Europe PubMed Central

5 December 2017

Emiel A M Janssen

1

object named as

Emiel A M Janssen

1 reference

Europe PubMed Central

5 December 2017

Paul J van Diest

4

object named as

Paul J van Diest

1 reference

Europe PubMed Central

5 December 2017

author name string

Marta Alonso Guervós

3

1 reference

Europe PubMed Central

5 December 2017

M Jiwa

5

1 reference

Europe PubMed Central

5 December 2017

Mario A J A Hermsen

6

1 reference

Europe PubMed Central

5 December 2017

publication date

1 December 2003

1 reference

Europe PubMed Central

5 December 2017

Journal of Pathology

1 reference

Europe PubMed Central

5 December 2017

201

1 reference

Europe PubMed Central

5 December 2017

555-561

1 reference

Europe PubMed Central

5 December 2017

4

1 reference

Europe PubMed Central

5 December 2017

Flow cytometry in primary breast carcinomas. Prognostic impact of proliferative activity

1 reference

https://api.crossref.org/works/10.1002%2FPATH.1475

21 January 2018

Genomic imbalances detected by comparative genomic hybridization are prognostic markers in invasive ductal breast carcinomas.

1 reference

https://api.crossref.org/works/10.1002%2FPATH.1475

21 January 2018

NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FPATH.1475

21 January 2018

Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1002%2FPATH.1475

21 January 2018

PIK3CA as an oncogene in cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FPATH.1475

21 January 2018

Telomerase activity and lymphovascular invasion in breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPATH.1475

21 January 2018

Phosphatidylinositol 3-kinase and NF-kappaB regulate motility of invasive MDA-MB-231 human breast cancer cells by the secretion of urokinase-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1002%2FPATH.1475

21 January 2018

Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity i

1 reference

https://api.crossref.org/works/10.1002%2FPATH.1475

21 January 2018

Comparison of the prognostic value of four methods to assess mitotic activity in 186 invasive breast cancer patients: classical and random mitotic activity assessments with correction for volume percentage of epithelium

1 reference

https://api.crossref.org/works/10.1002%2FPATH.1475

21 January 2018

Correlation between karyotypic pattern and clincopathologic features in 125 breast cancer cases

1 reference

https://api.crossref.org/works/10.1002%2FPATH.1475

21 January 2018

Genetic analysis of 53 lymph node-negative breast carcinomas by CGH and relation to clinical, pathological, morphometric, and DNA cytometric prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2FPATH.1475

21 January 2018

Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution

1 reference

https://api.crossref.org/works/10.1002%2FPATH.1475

21 January 2018

The prognostic value of the mitotic activity index in patients with primary breast cancer who were not treated with adjuvant systemic therapy

1 reference

https://api.crossref.org/works/10.1002%2FPATH.1475

21 January 2018

ARHI/NOEY2 inactivation may be important in breast tumor pathogenesis

1 reference

https://api.crossref.org/works/10.1002%2FPATH.1475

21 January 2018

ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancers

1 reference

https://api.crossref.org/works/10.1002%2FPATH.1475

21 January 2018

Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer

1 reference

https://api.crossref.org/works/10.1002%2FPATH.1475

21 January 2018

Telomerase activity and survival of patients with node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FPATH.1475

21 January 2018

Identifiers

10.1002/PATH.1475

1 reference

Europe PubMed Central

5 December 2017

1 reference

Europe PubMed Central

5 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44675764&oldid=2031562789"